OptimizeRx price target lowered to $8 from $16 at JMP Securities
JMP Securities lowered the firm’s price target on OptimizeRx (OPRX) to $8 from $16 and keeps an Outperform rating on the shares.
Similarweb price target raised to $17 from $16 at JMP Securities
JMP Securities raised the firm’s price target on Similarweb (SMWB) to $17 from $16 and keeps an Outperform rating on the shares. The ...
Nasdaq5d
OptimizeRx price target lowered to $8 from $16 at JMP Securities
JMP Securities lowered the firm’s price target on OptimizeRx (OPRX) to $8 from $16 and keeps an Outperform rating on the shares. OptimizeRx reported a disappointing Q3 miss and guide-down ...
Nasdaq5d
Similarweb price target raised to $17 from $16 at JMP Securities
JMP Securities raised the firm’s price target on Similarweb (SMWB) to $17 from $16 and keeps an Outperform rating on the shares. The company reported better-than-expected revenue and ...